{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:51Z","timestamp":1791357111195,"version":"4.3.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.genhosppsych.2007.11.002","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T04:45:33Z","timestamp":1214455533000},"page":"378-380","source":"Crossref","is-referenced-by-count":51,"title":["Cabergoline-induced psychotic exacerbation in schizophrenic patients"],"prefix":"10.1016","volume":"30","author":[{"given":"Shen-Chieh","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.genhosppsych.2007.11.002_bib1","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0920-9964(98)00159-5","article-title":"Neuroleptic-induced hyperprolactinemia","volume":"35","author":"Dickson","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF03345068","article-title":"Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders","volume":"23","author":"Tollin","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004714-198704000-00008","article-title":"Amantadine in the treatment of neuroendocrine side effects of neuroleptics","volume":"7","author":"Correa","year":"1987","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-198912000-00006","article-title":"The behavioral toxicity of bromocriptine in patients with psychiatric illness","volume":"9","author":"Perovich","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1176\/ajp.143.9.1170","article-title":"Exacerbation of schizophrenia associated with amantadine","volume":"143","author":"Nestelbaum","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003495-199549020-00009","article-title":"Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation","volume":"49","author":"Rains","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/104454601317261618","article-title":"Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children","volume":"11","author":"Cohen","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4088\/JCP.v65n0207","article-title":"Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study","volume":"65","author":"Cavallaro","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib9","first-page":"54","article-title":"Is cabergoline a better drug to inhibit lactation in patients with psychotic symptoms?","volume":"27","author":"Baeza Pertegaz","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00023210-200418130-00007","article-title":"Amisulpride: a review of its use in the management of schizophrenia","volume":"18","author":"McKeage","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4088\/JCP.v67n0612","article-title":"Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine","volume":"67","author":"Papakostas","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00002826-199619030-00002","article-title":"Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect","volume":"19","author":"Ahlskog","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.genhosppsych.2007.11.002_bib13","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1212\/01.WNL.0000147297.51023.C8","article-title":"Effective cabergoline treatment in idiopathic restless legs syndrome","volume":"63","author":"Stiasny-Kolster","year":"2004","journal-title":"Neurology"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016383430700223X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016383430700223X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T11:26:02Z","timestamp":1545909962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016383430700223X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S016383430700223X"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2007.11.002","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}